“…The normalization methods for the expression of miRNAs were not the same. However, 11 individual miRNAs (miR-10b-5p, miR-20a-5p, miR-21-5p, miR-22-3p, miR-30c-5p, miR-106b-5p, miR-122-5p, miR-181a-5p, miR-642b-3p, miR-885-5p, and let-7a-5p) and 3 panels (panel A: miR-196a-5p, and miR-196b-5p; panel B: miR-22-3p, miR-642b-3p, and miR-885-5p; panel C: miR-20a-5p, miR-21-5p, miR-24-3p, miR-25-3p, miR-99a-5p, miR-185-5p, and miR-191-5p) showed excellent sensitivity and specificity (both ≥90%) for all stages of [56][57][58][59]. Another panel of seven selected miRNAs (miR-20a-5p, miR-21-5p, miR-24-3p, miR-25-3p, miR-99a-5p, miR-185-5p, and miR-191-5p) from PDAC patients' serum was compared to normal controls.…”